Symbol="MORF"
AssetType="Common Stock"
Name="Morphic Holding Inc"
Description="Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small molecule integrin therapies for the treatment of autoimmune, cardiovascular, metabolic, fibrosis, and cancer diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1679363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="35 GATEHOUSE DRIVE A2, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2641370000"
EBITDA="-69930000"
PERatio="None"
PEGRatio="None"
BookValue="10.76"
DividendPerShare="0"
DividendYield="0"
EPS="-1.68"
RevenuePerShareTTM="1.774"
ProfitMargin="-0.924"
OperatingMarginTTM="-1.029"
ReturnOnAssetsTTM="-0.106"
ReturnOnEquityTTM="-0.172"
RevenueTTM="68947000"
GrossProfitTTM="-31254000"
DilutedEPSTTM="-1.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.781"
AnalystTargetPrice="73.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="14.03"
PriceToBookRatio="2.901"
EVToRevenue="9.32"
EVToEBITDA="-12.06"
Beta="1.104"
num_52WeekHigh="63.08"
num_52WeekLow="23.02"
num_50DayMovingAverage="56.75"
num_200DayMovingAverage="38.59"
SharesOutstanding="45825300"
DividendDate="None"
ExDividendDate="None"
symbol="MORF"
open="56.89"
high="58.42"
low="56.89"
price="57.64"
volume="270541.00"
latest_trading_day="2023-07-07"
previous_close="57.02"
change="0.62"
change_percent="1.0873%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="561872"
Change_recent_avg="0.08"
Delta_recent_avg="2.51"
Variance_recent_avg="1.26"
Change_ratio_recent_avg="0.1"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0059.jpeg"
image_negative_thumbnail_id_2="506"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0099.jpeg"
image_neutral_thumbnail_id_1="551"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_neutral_thumbnail_id_2="549"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_positive_thumbnail_id_1="650"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_positive_thumbnail_id_2="626"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
